Core Scientific, Inc.
CORZ- Exchange
- Nasdaq
- Industry
- Finance Services
- SEC CIK
- 0001839341
In the last 90 days, Core Scientific, Inc. insiders filed 3 open-market purchases and 13 sales; 412 institutions reported holding it in 13F filings for Q2 2026, worth $9.35B in total; 4 superinvestors hold it, including Oaktree Capital and Tiger Global Management.
Superinvestors holding CORZ, Q2 2026
4 superinvestors report holding Core Scientific, Inc. on Form 13F, worth $151.0M in total. Weight is Core Scientific, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Oaktree CapitalHoward Marks | 2.4% | 4,993,708 | $127.8M | Reduced−46.6% |
| Tiger Global ManagementChase Coleman | 0.1% | 817,000 | $20.9M | New |
| Third PointDaniel Loeb | <0.1% | 54,000 | $1.38M | New |
| Soros Fund ManagementGeorge Soros | <0.1% | 35,147 | $899.4K | Reduced−89.3% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CORZ each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
4 superinvestors holding at quarter end
- New
- Tiger Global Management, Third Point
- Reduced
- Oaktree Capital (−46.6%), Soros Fund Management (−89.3%)
Q1 2026
2 superinvestors holding at quarter end
- Added
- Oaktree Capital (+12.0%), Soros Fund Management (+5,935.6%)
Q4 2025
2 superinvestors holding at quarter end
- New
- Soros Fund Management
- Added
- Oaktree Capital (+30.5%)
- Sold out
- Third Point
Q3 2025
2 superinvestors holding at quarter end